Free guide helps GPs improve eye care knowledge

Article

The Royal College of General Practitioners and the UK Vision Strategy initiative have produced a new guide, Sight Loss in Older People: The Essential Guide for General Practice.

The Royal College of General Practitioners and the UK Vision Strategy initiative have produced a new guide, Sight Loss in Older People: The Essential Guide for General Practice.

The guide highlights the need and routes for early and appropriate referral, the link between sight loss and other health conditions, and suggests how services provided by general practice can be made more accessible for older people with sight loss.

The release of the guide comes after a recent survey revealed many GPs in the UK were not confident when diagnosing major eye diseases. Just one third (34.1%) of respondents were confident in spotting the symptoms of age-related macular degeneration, with only half of GPs confident in recognizing diabetic retinopathy (48.8%), glaucoma (51.2%), or refractive error (49.3%).

Sight Loss in Older People: The Essential Guide for General Practice, can be downloaded here.

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.